These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38093328)

  • 21. Human leukocyte antigen-A, -B, and -DRB1 haplotypes of cord blood units in the Tzu Chi Taiwan Cord Blood Bank.
    Wen SH; Lai MJ; Yang KL
    Hum Immunol; 2008 Jul; 69(7):430-6. PubMed ID: 18582515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of HLA Homozygous Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation.
    Morishima Y; Azuma F; Kashiwase K; Matsumoto K; Orihara T; Yabe H; Kato S; Kato K; Kai S; Mori T; Nakajima K; Morishima S; Satake M; Takanashi M; Yabe T;
    Stem Cells Transl Med; 2018 Feb; 7(2):173-179. PubMed ID: 29274116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of universal natural killer cells from a cryopreserved cord blood mononuclear cell-derived induced pluripotent stem cell library.
    Du W; Cui L; Zhang J; Zhang H; Liu R; Yang W; Zhang Y
    FEBS Open Bio; 2022 Oct; 12(10):1771-1781. PubMed ID: 35747945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications.
    Abberton KM; McDonald TL; Diviney M; Holdsworth R; Leslie S; Delatycki MB; Liu L; Klamer G; Johnson P; Elwood NJ
    Stem Cells Transl Med; 2022 Oct; 11(10):1052-1060. PubMed ID: 36073721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
    Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
    Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-resolution HLA-A, HLA-B, and HLA-DRB1 haplotype frequencies from the French Bone Marrow Donor Registry.
    Gourraud PA; Pappas DJ; Baouz A; Balère ML; Garnier F; Marry E
    Hum Immunol; 2015 May; 76(5):381-4. PubMed ID: 25637665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors.
    Sugita S; Iwasaki Y; Makabe K; Kimura T; Futagami T; Suegami S; Takahashi M
    Stem Cell Reports; 2016 Oct; 7(4):619-634. PubMed ID: 27641646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation of Clinical-Grade Induced Pluripotent Stem Cell Lines from Erythroid Progenitor Cells in Xenofree Conditions.
    Singh G; Manian KV; Premkumar C; Srivastava A; Daniel D; Velayudhan SR
    Methods Mol Biol; 2022; 2454():775-789. PubMed ID: 33950379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the HLA diversity of cord blood units collected from a birth clinic caring for pregnant women in an ethnically diverse metropolitan area.
    Magalon J; Billard-Daufresne LM; Gilbertas C; Hermanche E; Simon S; Lemarie C; Calmels B; Sabatier F; Gamerre M; Picard C; Chabannon C
    Transfusion; 2014 Apr; 54(4):1046-54. PubMed ID: 23944705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allele and Haplotype Frequencies of HLA-A, -B, -C, and -DRB1 Genes in 3,750 Cord Blood Units From a Kinh Vietnamese Population.
    Que TN; Khanh NB; Khanh BQ; Van Son C; Van Anh NT; Anh TTT; Tung PD; Thang ND
    Front Immunol; 2022; 13():875283. PubMed ID: 35844516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application.
    Alvarez-Palomo B; Vives J; Casaroli-Marano RPP; G Gomez SG; Rodriguez Gómez L; Edel MJ; Querol Giner S
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30965661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological considerations for embryonic and induced pluripotent stem cell banking.
    Taylor CJ; Bolton EM; Bradley JA
    Philos Trans R Soc Lond B Biol Sci; 2011 Aug; 366(1575):2312-22. PubMed ID: 21727137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells.
    Shafa M; Walsh T; Panchalingam KM; Richardson T; Menendez L; Tian X; Suresh Babu S; Dadgar S; Beller J; Yang F; Baghbaderani BA
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic hematopoietic stem cell transplant recipients in Spain: Human leukocyte antigen characteristics and diversity by high-resolution analysis.
    Guerreiro M; Planelles D; Aguilar-Gallardo C; Lorenzo JI; Montoro J; Sanz J; Balaguer A; Gómez I; Solves P; Pérez A; Blanquer M; Espigado I; Solano C; Piñana JL;
    HLA; 2021 Mar; 97(3):198-213. PubMed ID: 33369244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types.
    Taylor CJ; Peacock S; Chaudhry AN; Bradley JA; Bolton EM
    Cell Stem Cell; 2012 Aug; 11(2):147-52. PubMed ID: 22862941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1 Allele and Haplotype Frequencies of 28,927 Saudi Stem Cell Donors Typed by Next-Generation Sequencing.
    Jawdat D; Uyar FA; Alaskar A; Müller CR; Hajeer A
    Front Immunol; 2020; 11():544768. PubMed ID: 33193311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility.
    Xu H; Wang B; Ono M; Kagita A; Fujii K; Sasakawa N; Ueda T; Gee P; Nishikawa M; Nomura M; Kitaoka F; Takahashi T; Okita K; Yoshida Y; Kaneko S; Hotta A
    Cell Stem Cell; 2019 Apr; 24(4):566-578.e7. PubMed ID: 30853558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity.
    Flahou C; Morishima T; Takizawa H; Sugimoto N
    Front Immunol; 2021; 12():662360. PubMed ID: 33897711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Korea National Stem Cell Bank.
    Kim JH; Jo HY; Ha HY; Kim YO
    Stem Cell Res; 2021 May; 53():102270. PubMed ID: 33714852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.